Publications

Zhang YF, Chang CE, Varghese TK Jr, Tao R, Hashibe M. Increased risks of type II diabetes among older Asian, Native Hawaiian, and Pacific Islander[...]

Liu CM, Fischer JL, Lee MJ, Mace JC, Kimple AJ, Markarian K, Alt JA, Bodner TE, Chowdhury NI, Chung SY, Eshaghian PH, Gao YA, Getz[...]

Hecht JR, Oberoi A, Garralda Cabanas E, Jae Chon H, Digklia A, Rottey S, Martin Jimenez M, Chaney M, Hippenmeyer J, Lawrence T, Liu K,[...]

Duggirala N, Zhang S, Master A, Rao R, Kapoor NS, Bardia A, Lipsyc-Sharf M. Biology, care, and outcomes of gestational breast cancers: a review. Breast[...]

Borsky AE, Kroll-Desrosiers A, Rodriguez A, Fenwick K, Friedman JK, Yano EM. The State of VA-funded Women Veterans' Health Systems Research. Womens Health Issues. 2025[...]

Packard RRS, deKemp RA, Knuuti J, Moody JB, Renaud JM, Saraste A, Slomka PJ. Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis. J Nucl Cardiol.[...]

Yoo C, Ueno M, Klümpen HJ, Kelley RK, Vogel A, Furuse J, Ren Z, Yau T, Chan SL, Ozaka M, Oh SC, Gu S, Park[...]

Bransky NP, Kathuria-Prakash N, Sehl M. CRE25-032: Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-032. doi: 10.6004/jnccn.2024.7101. PMID: 40154331.

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J[...]

Bardia A, Pistilli B, Rugo H. Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer. J Clin Oncol. 2025 Mar 28:JCO2402833.[...]